Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
NAV17/05/2024 | Chg.-1.4800 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
198.8700CHF | -0.74% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV17/05/2024 | Chg.-1.4800 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
198.8700CHF | -0.74% | reinvestment | Equity Worldwide | Candriam ▶ |